- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sight Sciences Inc (SGHT)
Sight Sciences Inc stock price live, this page displays NASDAQ SGHT stock exchange data. View the SGHT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sight Sciences Inc real time stock price chart below.
What Is the Sight Sciences Inc Stock Price Today?
The Sight Sciences Inc stock price today is 4.20.
What Is the Stock Symbol for Sight Sciences Inc?
The stock symbol for Sight Sciences Inc is ""SGHT.""
What Stock Exchange Does Sight Sciences Inc Trade On?
Sight Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Sight Sciences Inc a Good Stock to Buy?
Determining whether Sight Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SGHT quote. (ISIN: US82657M1053)
What Is the Sight Sciences Inc Stock Price Today?
The Sight Sciences Inc stock price today is 4.20.
What Is the Stock Symbol for Sight Sciences Inc?
The stock symbol for Sight Sciences Inc is ""SGHT.""
What Stock Exchange Does Sight Sciences Inc Trade On?
Sight Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Sight Sciences Inc a Good Stock to Buy?
Determining whether Sight Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SGHT quote. (ISIN: US82657M1053)
NASDAQ
Currency in USD
Fair Value
An estimate of a Sight Sciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.06
4.28
52 wk Range
2.03
7.05
SGHT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SGHT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Sight Sciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.064.28
52 wk Range
2.037.05
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SGHT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sight Sciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
4.27
Upside
+1.59%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Sight Sciences Inc Company Profile
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeons to perform a comprehensive procedure indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and SION surgical instrument, a bladeless manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The company also provides TearCare system, a dry eye device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Sight Sciences Inc Earnings Call Summary for Q2/2025
- Q2 2025 revenue beat expectations at $19.6M, with EPS loss of $0.23, narrower than forecast; stock fell 3.53% after hours
- Surgical glaucoma revenue down 5% YoY to $19.2M; dry eye segment revenue dropped significantly to $300K from $1.1M in 2024
- Full-year 2025 revenue guidance raised to $72-76M; company expects return to growth in MIGS market by 2026
- CEO highlighted potential of Tier Care technology for dry eye segment; CFO noted strong sales team performance
- Challenges include declining dry eye revenue, MIGS market transition, and estimated $1-1.5M tariff exposure for 2025
Last Updated: 08/08/2025, 11:36
Read Full TranscriptCompare SGHT to Peers and Sector
Metrics to compare | SGHT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSGHTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.5x | −4.1x | −0.6x | |
PEG Ratio | −0.46 | −0.10 | 0.00 | |
Price/Book | 3.1x | 2.7x | 2.6x | |
Price / LTM Sales | 2.9x | 2.8x | 3.3x | |
Upside (Analyst Target) | −4.8% | 22.0% | 40.2% | |
Fair Value Upside | Unlock | 11.5% | 5.1% | Unlock |
Analyst Ratings
3 Buy
4 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 4.27
(+1.59% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
-0.23 / -0.26
Revenue / Forecast
19.60M / 18.18M
People Also Watch
FAQ
What Stock Exchange Does Sight Sciences Trade On?
Sight Sciences is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Sight Sciences?
The stock symbol for Sight Sciences is "SGHT."
What Is the Sight Sciences Market Cap?
As of today, Sight Sciences market cap is 219.94M.
What Is Sight Sciences's Earnings Per Share (TTM)?
The Sight Sciences EPS (TTM) is -0.96.
When Is the Next Sight Sciences Earnings Date?
Sight Sciences will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is SGHT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sight Sciences Stock Split?
Sight Sciences has split 0 times.
How Many Employees Does Sight Sciences Have?
Sight Sciences has 216 employees.
What is the current trading status of Sight Sciences (SGHT)?
As of 18 Aug 2025, Sight Sciences (SGHT) is trading at a price of 4.20, with a previous close of 4.20. The stock has fluctuated within a day range of 4.06 to 4.28, while its 52-week range spans from 2.03 to 7.05.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.